TrialCell reports. Medicine2020

Clonal Evolution and Heterogeneity of Osimertinib Acquired Resistance Mechanisms in EGFR Mutant Lung Cancer.

Nitin Roper et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.